article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Population Studied individuals with comorbidity of hypertension and type 2 diabetes. Setting or Dataset Five electronic systems of community clinic.

article thumbnail

DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes

Physician's Weekly

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D., Pilla, M.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure. WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. All rights reserved.

article thumbnail

Revisiting the Advantages of aSOAP Notes: The Best of the Paper Chart and Old School Photography

A Country Doctor Writes

I don’t really need the details in order to know how to consider this patient’s risk for future cardiac events. Or it may look like these examples: 60 year old male with hypertension, COPD and anticoagulated atrial fibrillation returns for followup. His 10 year cardiovascular risk is average but his BMI is approaching 30.

article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. Published in May 2024, the FLOW trial , for instance, looked at patients with diabetes and advanced kidney disease.

article thumbnail

Guidelines or Goals in Heart Failure: A Podcast with Parag Goyal, Nicole Superville, and Matthew Shuster

GeriPal

He was describing his, like, 87 year old grandma who was placed on a low salt diabetic diet. So I have a two and a half year old, and during my last pregnancy, I had gestational diabetes. If they’re frail, if they’re falling, if they have cognitive impairment, they’re at higher risk of adverse drug events.

article thumbnail

On Racism & Ageism: Ramona Rhodes, Sharon Brangman, Tim Farrell, and Nancy Lundebjerg

GeriPal

Don’t worry about it,” or they never had good treatment for their hypertension for so many years or their diabetes, so they were much, much more advanced at a younger age. Because we know- Sharon: Maybe diabetes and hypertension, which is so prominent in African Americans can impact your amyloid deposition.

IT 92